$PODD

AI Analysis

Generated on May 11, 2026

AI Score
72/ 100
Hold$PODD

Insulet Corporation

$PODDNASDAQHealthcareLarge-Cap

Insulet develops the Omnipod insulin management system, a tubeless insulin pump for diabetes management.

Market Cap
$18.0B
Revenue (TTM)
$2.2B
+18.0%
Net Income (TTM)
$0.2B
+25.0%
EPS (TTM)
$2.80
P/E Ratio
72.0
Dividend Yield
0.0%
52-Week Range
$155-$275
Beta
0.82
Dimension Scores
Fundamental
66
Technical
68
Sentiment
76
Risk / Reward
64
Momentum
78
FundTechSentRiskMome
Financial Health
Profitability
71moderate
Growth
81strong
Liquidity
72strong
Solvency
68strong
Efficiency
64strong

Valuation, technical analysis, investment thesis, risk assessment and more for $PODD

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.